Aicuris announced today the appointment of Jacques Dumas, Ph.D., as Chief Scientific Officer (CSO), effective January 1, 2025. Dr. Dumas brings over 30 years of experience in pharmaceutical research ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Hold rating on Amgen (AMGN – Research Report), with a ...

Truist lowered the firm’s price target on Amgen (AMGN) to $298 from $333 and keeps a Hold rating on the shares as part of a broader research ...

In the latest market close, Amgen (AMGN) reached $262.05, with a +1.34% movement compared to the previous day. This change outpaced the S&P 500's 1.11% loss on the day. Meanwhile, the Dow experienced ...

Amgen Inc. closed $84.79 short of its 52-week high ($346.85), which the company achieved on July 25th.

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

Amgen Inc (AMGN) stock saw a decline, ending the day at $258.59 which represents a decrease of $-2.63 or -1.01% from the prior close of $261.22. The stock opened at $259.05 and touched a low of ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

The annual awards are named after "pharma bro" Martin Shkreli, who was sentenced to 7 years in prison and fined $7.4 million ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

CytomX’s workforce cuts could leave the biotech with fewer than 75 employees as it focuses resources on its wholly owned ...